Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Anesthetic for Pain Control During Q-Switched 532nm Laser Treatment
NCT02427724Phase 1Completed
- Sponsor
- Northwestern University
- Start
- Apr 2015
- Primary completion
- May 2024
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 1, randomised trial of lidocaine 10% oropharyngeal spray, prilocaine and tetracaine in lentigo (3 arms), sponsored by Northwestern University. Primary endpoint: Visual Analog Scale pain rating. Started Apr 2015; status: completed.
02
Drugs
lidocaine 10% oropharyngeal sprayprilocainetetracaine
03
Conditions
lentigo
Beyond the preview
Go deeper on NCT02427724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02427724.